Moral dilemmas in perinatal medicine and the quest for large scale embryo research: a discussion of recent guidelines in the Federal Republic of Germany.
This paper reports on recent regulations and guidelines in the Federal Republic of Germany bearing on perinatal medical ethics, embryo research and trophoblast biopsy. Some of the regulations are defensive responses to new moral opportunities. In contrast, this paper calls for a more aggressive moral cost-benefit assessment of high technology medicine, which would include large-scale research on embryos prior to the fiftieth day post-menstruation.
Sass
H M
HM
Ruhr Universitat, Federal Republic of Germany.
D000028:Abortion, Induced; D000328:Adult; D033421:Beginning of Human Life; D033041:Embryo Research; D004622:Embryo, Mammalian; D028741:Ethics Committees, Clinical; D028744:Ethics Committees, Research; D004992:Ethics, Medical; D005260:Female; D005860:Germany, West; D033161:Government Regulation; D006806:Human Rights; D006801:Humans; D007231:Infant, Newborn; D019369:Life; D009014:Morals; D026706:Paternalism; D018579:Patient Selection; D010500:Perinatology; D028723:Personhood; D011247:Pregnancy; D012106:Research / Q000592:standards*; D018570:Risk Assessment; D012732:Sex Determination Analysis; D012926:Social Control, Formal; D026712:Value of Life; D028761:Withholding Treatment